HUDI - Huadi International Grp Co Ltd Latest Stock News & Market Updates

Ocugen (OCGN) has signed a licensing agreement with Roots Pharmaceutical and Al-Dhow International for OCU400, a gene therapy for retinitis pigmentosa, in the Middle East and North Africa. The deal includes upfront payments, potential milestones up to $255M, and 22% royalties. Ocugen will manufacture and supply the therapy, aiming to address high disease prevalence in the region.

Joby Aviation aims to be a transportation-as-a-service company with its eVTOL aircraft, making progress with FAA-compliant and autonomous technology. Viking Therapeutics is developing obesity drug VK2735, showing promising weight loss data in trials. Both companies are high-risk, high-reward investments.

Verastem Oncology (VSTM) appointed Michael P. Bailey as CEO, effective January 1, 2027. Bailey succeeds Daniel Paterson, who will remain as an advisor. Bailey has 30 years of biopharmaceutical experience, including 25 in oncology. VSTM shares rose nearly 20% in pre-market trading, closing at $7.45 on Tuesday.

Bernstein lowered its price target for General Dynamics (GD) to $365 from $407. The stock closed at $332.42, down 0.91% on the day and up 0.33% over the past year. Deutsche Bank also reduced its target to $353 from $384.

JPMorgan downgraded Bruker to 'Neutral' from 'Overweight' and set a price target of $60. The company's stock has seen a 5-day change of 56.19 USD, a 1st Jan change of -0.11%, and a 19.27% increase over a longer period.

Nvidia, valued at $5.5tn, is donating $250m in computing power to the UK over five years for AI safety research. The funds will support various UK research initiatives and the AI Security Institute, which tests advanced AI models from companies like OpenAI and Google. According to Nvidia, the donation aims to enhance AI safety and security research.